Reviewed profile

food and beverage brand · public preview

Therapeutics

Retail brand

Public category
Retail brand
Brand tier
mainstream brand
Is this your company?Claim Therapeutics to get found by buyers, add products and certifications, correct your details, and be eligible when Talio’s AI recommends suppliers.Let our AI make the introductionGet a warm, researched intro to Therapeutics — no cold outreach.
Report a changeLog in for full recordLast reviewed 28 Mar 2026 · public preview data

Overview

What Therapeutics covers.

TG Therapeutics is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for B-cell-mediated diseases. The company's marketed product, BRIUMVI (ublituximab), is indicated for the treatment of relapsing forms of multiple sclerosis (MS) in adults. Its pipeline also includes other investigational agents like AzerCel, targeting various hematologic malignancies and autoimmune disorders. The company directs its scientific efforts toward developing targeted therapies for patients with significant unmet medical needs.

  • Positioned as a mainstream brand.

FAQ

Questions this page answers.

What does Therapeutics do?

Therapeutics is a food and beverage brand, tracked in Talio's food and beverage intelligence platform.

Is this the full Talio record?

No. This page is a public preview; proprietary metrics and workflow features remain inside authenticated Talio.

Own this company?

Get found by buyers — and the AI that recommends suppliers.

Claim this profile to appear in buyer searches, add your products and certifications, correct outdated details, and stay eligible when Talio's AI recommends suppliers.

Claiming grants reviewed submission rights only — not direct editing, suppression, or ownership of Talio-derived intelligence. Verification required.

Claim this pageLog in for full recordReport a change

Public preview data only · proprietary metrics remain in authenticated Talio.